These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34931119)

  • 1. Pierce into Structural Changes of Interactions Between Mutated Spike Glycoproteins and ACE2 to Evaluate Its Potential Biological and Therapeutic Consequences.
    Hashemi ZS; Zarei M; Mubarak SMH; Hessami A; Mard-Soltani M; Khalesi B; Zakeri A; Rahbar MR; Jahangiri A; Pourzardosht N; Khalili S
    Int J Pept Res Ther; 2022; 28(1):33. PubMed ID: 34931119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction.
    Santra D; Maiti S
    Struct Chem; 2022; 33(5):1755-1769. PubMed ID: 35966763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F; Sami H
    J King Saud Univ Sci; 2022 Feb; 34(2):101773. PubMed ID: 34955621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces.
    Dos Santos VP; Rodrigues A; Dutra G; Bastos L; Mariano D; Mendonça JG; Lobo YJG; Mendes E; Maia G; Machado KDS; Werhli AV; Rocha G; de Lima LHF; de Melo-Minardi R
    PeerJ; 2022; 10():e13099. PubMed ID: 35341044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.
    Gan HH; Twaddle A; Marchand B; Gunsalus KC
    J Mol Biol; 2021 Jul; 433(15):167051. PubMed ID: 33992693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates.
    Williams AH; Zhan CG
    J Phys Chem B; 2021 May; 125(17):4330-4336. PubMed ID: 33881861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex.
    Ahmed WS; Philip AM; Biswas KH
    Front Mol Biosci; 2022; 9():846996. PubMed ID: 35936792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution.
    Erausquin E; Glaser F; Fernández-Recio J; López-Sagaseta J
    Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1156-1170. PubMed ID: 36048155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.
    Rostami N; Choupani E; Hernandez Y; Arab SS; Jazayeri SM; Gomari MM
    J Cell Biochem; 2022 Feb; 123(2):417-430. PubMed ID: 34783057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike.
    Banerjee A; Kanwar M; Santra D; Maiti S
    Transl Med Commun; 2022; 7(1):2. PubMed ID: 35136839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Chakraborty S
    Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
    Cao Z; Wang LT; Liu ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):150-158. PubMed ID: 33550350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.
    Aljindan RY; Al-Subaie AM; Al-Ohali AI; Kumar D T; Doss C GP; Kamaraj B
    Comput Biol Med; 2021 Aug; 135():104654. PubMed ID: 34346317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
    Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
    Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.